17782-81-9 Usage
General Description
Imidazo[2,1-b]thiazole-5-carboxylic acid is a chemical compound containing a fused imidazole and thiazole ring system attached to a carboxylic acid group. Due to its complex aromatic structure, this compound may have different applications in the chemical, pharmaceutical, and biotechnological industry. It might be involved in the creation of various organic compounds used for research or as intermediate substance in drug manufacturing. Its properties, toxicity, and potential use depend on its molecular structure and derived modifications, as well as stabilization methods. Detailed information on the chemical's properties require further studies.
Check Digit Verification of cas no
The CAS Registry Mumber 17782-81-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,7,8 and 2 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 17782-81:
(7*1)+(6*7)+(5*7)+(4*8)+(3*2)+(2*8)+(1*1)=139
139 % 10 = 9
So 17782-81-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H4N2O2S/c9-5(10)4-3-7-6-8(4)1-2-11-6/h1-3H,(H,9,10)
17782-81-9Relevant articles and documents
2-CYCLOPROPYL-THIAZOLE DERIVATIVES
-
Page/Page column 25, (2010/09/07)
The invention relates to selected 2-cyclopropyl-thiazole derivatives of the formula (I) wherein B, Y and R1 are as described in the description; to salts and especially pharmaceutically acceptable salts thereof, and to the use of such compounds use as med
3-AZA-BICYCLO[3.3.0]OCTANE COMPOUNDS
-
Page/Page column 47, (2009/03/07)
The invention relates to 3-aza-bicyclo[3.3.0]octane derivatives of the formula (I) wherein R1, R2, R3, and A are as described in the description and their use as orexin receptor antagonists.
2-CYCLOPROPYL-THIAZOLE DERIVATIVES
-
, (2009/01/20)
The invention relates to selected 2-cyclopropyl-thiazole derivatives of the formula (I) wherein B, Y and R1 are as described in the description; to salts and especially pharmaceutically acceptable salts thereof, and to the use of such compounds use as medicaments, especially as orexin receptor antagonists.
